Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Green Med Solution (BGMS) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Bio Green Med Solution (BGMS) over the last 8 years, with Q3 2025 value amounting to $1.9 million.

  • Bio Green Med Solution's Shares Outstanding (Diluted Average) rose 418033.17% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 418033.17%. This contributed to the annual value of $11.3 million for FY2022, which is 2609.75% up from last year.
  • Latest data reveals that Bio Green Med Solution reported Shares Outstanding (Diluted Average) of $1.9 million as of Q3 2025, which was up 418033.17% from $44681.0 recorded in Q3 2024.
  • Bio Green Med Solution's Shares Outstanding (Diluted Average)'s 5-year high stood at $11.9 million during Q3 2023, with a 5-year trough of $44681.0 in Q3 2024.
  • In the last 5 years, Bio Green Med Solution's Shares Outstanding (Diluted Average) had a median value of $9.4 million in 2023 and averaged $8.4 million.
  • Per our database at Business Quant, Bio Green Med Solution's Shares Outstanding (Diluted Average) tumbled by 9962.46% in 2024 and then surged by 418033.17% in 2025.
  • Quarter analysis of 5 years shows Bio Green Med Solution's Shares Outstanding (Diluted Average) stood at $8.9 million in 2021, then rose by 26.1% to $11.3 million in 2022, then rose by 5.75% to $11.9 million in 2023, then tumbled by 99.62% to $44681.0 in 2024, then skyrocketed by 4180.33% to $1.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $1.9 million for Q3 2025, versus $44681.0 for Q3 2024 and $11.9 million for Q3 2023.